SCHEMBL3465802

SCHEMBL3465802

CCC(OS(=O)(=O)c1ccc(C)cc1)N(C(=O)OC(C)(C)C)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
XBP1 P17861 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MMP13 P45452 2/20 0.36
CYP24A1 Q07973 1/20 0.35
F2 P00734 2/20 0.35
CA2 P00918 2/20 0.34
NR1D1 P20393 1/20 0.34
CA1 P00915 1/20 0.34
CA4 P22748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6272255 0.80 KMT2A (0.39) ALDH1A1MEN1KMT2AGAAMMP13
SCHEMBL7521777 0.77 MMP13 (0.39) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL6272258 0.76 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ALMNAMMP13
SCHEMBL995108 0.74 AGER (0.41) ALDH1A1LMNAGAACA2CA1
SCHEMBL10771357 0.73 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ALMNATP53
SCHEMBL11171683 0.73 NR1D1 (0.38) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL7412821 0.73 KMT2A (0.41) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL7366077 0.73 KMT2A (0.41) ALDH1A1MEN1KMT2ALMNAGAA
SCHEMBL4440006 0.73 STAT5B (0.36) ALDH1A1MEN1KMT2AMMP13CYP24A1
SCHEMBL7548342 0.72 MMP13 (0.40) ALDH1A1MEN1KMT2AMMP13F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240656-A1 COMPOUNDS AS HSP90 INHIBITORS ORYZON GENOMICS, S.A. (ES) 2010-09-23 US disclosed
EP-2183221-A1 NEW COMPOUNDS AS HSP90 INHIBITORS Crystax Pharmaceuticals S.L. (ES) 2010-05-12 EP disclosed
WO-2009007399-A1 NEW COMPOUNDS AS HSP90 INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240656-A1 COMPOUNDS AS HSP90 INHIBITORS HSP90AB1, HSP90AB2P, HSP90AA1 ALDH1A1 1875/4885MEN1 4594/4885KMT2A 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.